Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil

NCT03960385 is registered in ClinicalTrials.gov with Albert B. Sabin Vaccine Institute as lead sponsor.

NCT NCT03960385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03960385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil
Lead sponsor
Albert B. Sabin Vaccine Institute
Phase
Observational
Overall status
Completed
Start date
August 1, 2017
Completion date
March 1, 2020
Enrollment
1,854 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue